# OnCo record evofosfamide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/evofosfamide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "evofosfamide" ;
  schema:name "Evofosfamide"@en ;
  schema:description "Evofosfamide was the most advanced hypoxia-activated drug, designed to kill the oxygen-starved tumour cells radiotherapy and chemotherapy miss, but it failed both of its phase 3 trials in 2015."@en ;
  schema:url <https://onco.cc/drugs/evofosfamide/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://en.wikipedia.org/wiki/Evofosfamide> ;
  onco:status "negative" ;
  onco:tag "radiation-wave3" ;
  onco:modality "Hypoxia-activated prodrug (small molecule alkylating agent)" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/tumour-hypoxia-modification/> ;
  onco:companies <https://onco.cc/companies/threshold-pharmaceuticals/> .